Matthew Peterson

Title: Innovations of Matthew Peterson in Crystalline Forms of Trofinetide

Introduction: Matthew Peterson, an inventive mind based in San Diego, CA, is recognized for his significant contribution to the pharmaceutical industry through his innovative work on crystalline forms of trofinetide. With one patent to his name, Peterson showcases his dedication to improving medical treatments and advancing pharmaceutical sciences.

Latest Patents: Matthew Peterson holds a patent titled "Crystalline forms of trofinetide." This disclosure details various crystalline forms of trofinetide and trofinetide hydrate, alongside pharmaceutical compositions that incorporate these forms. The patent also outlines methods of producing crystalline forms of trofinetide or trofinetide hydrate and explores therapeutic methods for treating diseases, conditions, or disorders by administering these compositions to patients.

Career Highlights: As a member of Acadia Pharmaceuticals Inc., Matthew has made a significant impact through his research and innovative efforts. His work focuses on enhancing pharmaceutical formulations that can ultimately benefit numerous patients suffering from various conditions.

Collaborations: Matthew collaborates with esteemed colleagues, including Marlon Carlos and Martin Bernard Catherine Bousmanne. Together, they bring a wealth of knowledge and expertise to their projects, contributing to the advancement of medical science and innovation in drug development.

Conclusion: Matthew Peterson’s dedication to innovation in the pharmaceutical sector, particularly with his patent on crystalline forms of trofinetide, exemplifies the important role inventors play in the development of effective medical treatments. His collaboration with talented coworkers at Acadia Pharmaceuticals Inc. further highlights the collaborative nature of scientific research, ultimately aiming to improve patient outcomes through advanced therapeutic options.